4//SEC Filing
Blischak Matthew P. 4
Accession 0000899243-23-015198
CIK 0001733257other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:52 PM ET
Size
5.6 KB
Accession
0000899243-23-015198
Insider Transaction Report
Form 4
Blischak Matthew P.
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-06-08+962,899→ 962,899 totalExercise: $0.28Exp: 2033-06-07→ Common Stock (962,899 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on June 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001975225
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:52 PM ET
- Size
- 5.6 KB